Brandon just caught institutional money making their biggest precious metals bet in months.
While everyone celebrates the S&P bouncing off its 50-day moving average, the real story is unfolding in gold. Today’s market rally looks impressive on the surface with the S&P up 1.4%. Strip away Broadcom’s 11% moonshot and you find something fascinating. Gold is the only asset outperforming technology stocks.
That tells you everything about what’s actually driving this market higher. Dollar weakness, not genuine strength.
Brandon spotted the smoking gun in today’s Ghost Prints data: someone just deployed 58,000 contracts on a GLD call spread targeting $410 by December 19th. That’s not retail money. That’s massive institutional positioning ahead of what could be gold’s strongest seasonal period.
The historical pattern backs this up. Gold has bottomed in November or early December for 14 consecutive years, then rallied through December into January and sometimes February. We’re seeing that setup again right now.
But the precious metals trade extends beyond just gold. Brandon found several confirming signals:
- B2 Gold showing 3,000 contracts targeting $6 as the stock tests multi-year highs
- First Majestic Silver with bullish call buying at the $13.50 strike
- AG showing short squeeze potential with heavy call volume
The broader market context matters here. Technology is the only sector outperforming the S&P today, and that performance comes almost entirely from one stock. When gold outperforms the index, it signals the market isn’t gaining real value. It’s just rising in price because the dollar is declining.
Brandon’s also tracking the crypto connection. Friday’s prints in IBIT and Bitcoin-related names are already paying off, with his alert positioning for 70% gains as IBIT targets $53. Tesla hit his exact $440 call target from Friday. KWEB surged 2.85%, beating even Nvidia’s performance.
The setup for year-end is clear. Fed dovishness combined with dollar weakness creates the perfect environment for precious metals to surge into January. Institutional money is positioning now, before this becomes obvious to everyone else.
There’s one bearish setup worth watching too. Someone bought 50,000 XBI put contracts targeting $100 by March. Biotech just hit highs and is vulnerable to a short-term pullback. That creates an opportunity to play both sides of this market at a pivotal moment.
The prints are leading price movement right now. These massive institutional trades aren’t random. They’re telegraphing where smart money expects the next big moves.
